基于数据挖掘探析吕文良教授治疗慢性乙型肝炎的用药规律

Abstract
Figure/Table
References (28)
Related Citation (15)

Download: PDF (1968 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To explore the medication rule of Professor Lü Wenliang in the treatment of chronic hepatitis B based on data mining, and to hope to provide reference for clinical treatment. Methods From January 2020 to July 2021, patients clearly diagnosed with chronic hepatitis B visited the expert outpatient clinic of Professor Lü at Department of Infectious Diseases, Guang’anmen Hospital, Chinese Academy of Chinese Medical Sciences were selected, and the clinical cases were real, complete and effective. The clinical case data were screened and a database was constructed, and data mining methods such as frequency statistics, association rule analysis, cluster analysis, complex system entropy clustering, and entropy tomographic clustering analysis were used to explore their medication rules. Results A total of 116 prescriptions were included, involving 153 traditional Chinese medicines. There were 13 traditional Chinese medicines with the use frequency of more than 50%, among which, the use frequency of raw Astragali Radix exceeded 95%. There were a total of ten drug combinations with frequency of usage ≥76, of which raw Astragali Radix, Scutellariae Radix, fried Atractylodis Macrocephalae Rhizoma, Saposhnikoviae Radix, Coptidis Rhizoma, Poria, scorched Crataegi Fructus, fried Armeniacae Semen Amarum, Phellodendri Chinensis Cortex were nine high frequency drugs. The drug properties were mainly cold and warm, and the drug tastes were mainly bitter and sweet, which were mainly attributed to the spleen, stomach, lung and liver channels. In the end, 14 pairs of core drug combinations and 14 new derivatives were selected and extracted. Conclusion Professor Lü takes the main treatment methods of enhancing qi and invigorating spleen, simultaneously dispersing stagnated liver qi, clearing dampness and heat, and directly eliminating poisonous pathogens, and can increase or decrease the drug according to the dynamic changes of the patient’s symptoms and disease stage. This study can provide a reference for Chinese medicine treatment of chronic hepatitis B.

Key words： Chronic hepatitis B Medication rule Traditional Chinese medicine inheritance platform Association rules Clustering algorithm Lü Wenliang

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	QIANG Rui FENG Jiaqi LYU Wenliang

Cite this article:

QIANG Rui FENG Jiaqi LYU Wenliang. Medication rule analysis of Professor Lü Wenliang in the treatment of chronic hepatitis B based on data mining[J]. 中国医药导报, 2022, 19(22): 104-109,113.

URL:

https://www.yiyaodaobao.com.cn/EN/ OR https://www.yiyaodaobao.com.cn/EN/Y2022/V19/I22/104

[1] Liu J，Liang W，Jing W，et al. Countdown to 2030：eliminating hepatitis B disease，China [J]. Bull World Health Organ，2019，97（3）：230-238.
[2] 邓晓靖，雷亚云，曹贵霞，等.慢性乙型病毒性肝炎中医证候蛋白质组学研究进展[J].世界科学技术-中医药现代化，2021，23（4）：1228-1234.
[3] 龙飘，房盛懿，杨雨莹，等.基于网络药理学和实验验证探讨苦参治疗乙型病毒性肝炎的作用机制[J].湖南中医药大学学报，2022，42（2）：271-277.
[4] 中华中医药学会肝胆病专业委员会，中国民族医药学会肝病专业委员会.慢性乙型肝炎中医诊疗指南（2018年版）[J].中西医结合肝病杂志，2019，29（1）：附Ⅰ-附Ⅵ.
[5] 中华医学会感染病学分会，中华医学会肝病学分会.慢性乙型肝炎防治指南（2019年版）[J].临床肝胆病杂志，2019，35（12）：2648-2669.
[6] 国家药典委员会.中华人民共和国药典[M].二部.北京：中国科技医药出版社，2020.
[7] Du X，Zhao B，Li J，et al. Astragalus po1ysacchaIides enhance immune responses of HBV DNA vaccination via promoting the dendritic cell maturation and suppressing Treg frequency in mice [J]. Int Immunophamacol，2012，14（4）：463-470.
[8] 蒋园，白云，刘萍，等.黄芪甲苷对CCL4所致小鼠肝损伤的影响[J].中药药理与临床，2015，31（6）：24-27.
[9] 刘印华，李树义，赵志强，等.黄芪多糖对免疫功能影响的体外实验研究[J].河北医药，2014，36（18）：2731-2733.
[10] 程玥，丁泽贤，张越，等.不同茯苓提取物对急性肝损伤小鼠的保护作用[J].安徽中医药大学学报，2020，39（4）：73-77.
[11] 李铮.白术挥发油对小鼠急性肝损伤的作用及其机制[D].长春：吉林大学，2020.
[12] 姜超，李伟，郑毅男.防风提取物对肝脏的保护作用[J].吉林农业大学学报，2014，36（3）：306-309.
[13] 滕磊，柴宇琪，忻耀杰，等.基于《长沙药解》探析黄芩、黄连和黄柏的临床效用之别[J].上海中医药大学学报，2018，32（2）：7-10.
[14] 陈梅，王盼盼，贾六金，等.黄连汤方义探析及临床应用[J].辽宁中医药大学学报，2021，23（5）：162-165.
[15] 赖杏荣，顾成娟，朴春丽.仝小林运用黄柏、生蒲黄、橘核治疗湿热瘀阻型慢性前列腺炎[J].吉林中医药，2021， 41（2）：170-172.
[16] 黄新造，柯文炳，占桂香，等.肝苏胶囊联合黄芩苷胶囊治疗慢性乙型病毒性肝炎的临床研究[J].现代药物与临床，2017，32（2）：271-274.
[17] 黄培瑜，赖晓琴，张雅兰，等.黄芩苷在乙型病毒性肝炎大鼠模型中调节肝功能损伤的机制研究[J].免疫学杂志，2020，36（12）：1091-1098.
[18] 吴颖瑞，马云宝，赵友兴，等.岩黄连的抗乙肝病毒活性成分研究[J].中草药，2012，43（1）：32-37.
[19] 李颖，马妮，顾健，等.民族药古山龙与黄柏保肝退黄作用对比研究[J].中药药理与临床，2019，35（2）：102-104.
[20] 张晓晖，刘洋，肖永华.肝阳虚临床证治辨析及气味配伍理论在肝阳虚治疗中的运用[J].环球中医药，2021， 14（5）：883-886.
[21] 董嘉琪，陈金鹏，龚苏晓，等.山楂的化学成分、药理作用及质量标志物（Q-Marker）预测[J].中草药，2021，52（9）：2801-2818.
[22] 杨悦，刘颖，刘晓谦，等.基于超高效液相色谱串联质谱技术的山楂核抗菌、抗氧化药效物质基础研究[J].世界中医药，2021，16（17）：2527-2532，2541.
[23] 封若雨，朱新宇，张苗苗.近五年山楂药理作用研究进展[J].中国中医基础医学杂志，2019，25（5）：715-718.
[24] Tang F，Fan K，Wang K，et al. Amygdalin attenuates acute liver injury induced by D-galactosamine and lipopolysaccha-ride by regulating the NLRP3，NF-κB and Nrf2/NQOl sig-nalling pathways [J]. Biomed Pharmacother，2019，111：527-536.
[25] 李加慧.抗病毒中药的性-效-病关联规则与临床选药思路研究[D].南京：南京中医药大学，2019.
[26] 刘晓燕，崔亚东，田合禄.中医四气五味理论与脏腑补泻关系的探讨[J].世界中医药，2021，16（1）：121-124， 129.
[27] 李丽，孙立丽，任晓亮，等.基于关联分析的吴茱萸与8味甘味药配伍作用规律研究[J].天津中医药大学学报，2021，40（6）：770-777.
[28] 刘梦玲，章新友，丁亮，等.数据挖掘方法在中药配伍规律研究中的应用与进展[J].中国中药杂志，2021，46（20）：5233-5239.